ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AMRN vs QTTB // EV/EBITDA & P/E VALUATION

Amarin Corporation plc (NASDAQ) VS. Q32 Bio Inc. (NASDAQ) • 15-METRIC TALLY: AMRN 2 — QTTB 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMRN VS. QTTB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AMRN QTTB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 56.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -12.20% 85.00% -97.20 QTTB /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 12.8x — TIE /valuation <GO>
Free Cash Flow Yield 2.56% -12.70% +15.26 AMRN /fcf-yield <GO>
Operating Margin -23.50% 31.50% -55.00 QTTB /operating-margins <GO>
Net Profit Margin -18.20% 55.50% -73.70 QTTB /net-margins <GO>
Revenue Growth (YoY) -6.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 5.99 -5.79 QTTB /balance-sheet <GO>
Piotroski F-Score Quality 6/9 4/9 +2.00 AMRN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.6 48.1 -1.47 QTTB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 8.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $262.8M $264.1M -$1.3M QTTB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AMRN REV QTTB REV AMRN GROSS % QTTB GROSS % AMRN FCF QTTB FCF
FY 2025 $213.6M $53.7M 56.6% — $6.7M -$33.5M
FY 2024 $228.6M $0 35.6% — -$31.0M -$67.8M
FY 2023 $306.9M $1.2M — — $6.9M -$18.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMRN // BETA —
QTTB // BETA —